Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-17

FDA Approved: ZYNRELEF — Supplemental Application (Heron Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZYNRELEF (bupivacaine and meloxicam) from Heron Therapeutics, Inc., expanding the regulatory approval for the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

SUPPL AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)